All In Biotech

Drug Trial Radar · NCT02976675

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Randomized, Open-label, Parallel Phase IV Clinical Trial With Different Administration Frequency of PEG Somatropin

Last checked: Nov 20, 2026Latest source record: Jun 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

600

Planned (sponsor's estimate)

Start

Jan 2015

Primary completion

Jun 2017

Sponsor

Sponsor type
Industry
Collaborators
Children's Hospital of Fudan University; Suzhou Municipal Hospital; General Hospital of Ningxia Medical University; The First Affiliated Hospital of Henan University of Science and Technology; Maternal and Child Health Hospital of Hubei Province; Nantong University
First posted
Nov 29, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 3 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of PEG Somatropin Injection in the treatment of children with growth hormone deficiency, as well as to study the feasibility of extending the dosing intervals (once per two weeks) of PEG Somatropin Injection.

Conditions

  • Growth Hormone Deficiency

Interventions

  • PEG-somatropinBiological

    Pegylated somatropin, injection, 54IU/9.0mg/1.0ml/bottle Group of dosing per week:0.20 mg /kg/w, once per week for 26 weeks

  • PEG-somatropinBiological

    Pegylated somatropin, injection, 54IU/9.0mg/1.0ml/bottle Group of dosing per two weeks:0.20 mg /kg/2w,once per two weeks for 26 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ht SDScaTime frame: Baseline, 4,12,26 weeks after initiating treatment

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Jishuitan Hospital of Beijing City

    Beijing, China · Recruiting

  • Peoples' hospital of Inner Mongolia Autonomous Region

    Inner Mongolia Autonomous Region, China · Recruiting

  • General Hospital of Ningxia Medical University

    Ningxia Autonomous Region, China · Recruiting

  • Children's Hospital of Fudan University

    Shanghai, China · Recruiting

  • Maternal and Child Health Hospital of Anhui province

    Hefei, Anhui, China · Recruiting

  • First People's Hospital of Lu'an City

    Lu'an, Anhui, China · Recruiting

  • Second Hospital of Lanzhou University

    Lanzhou, Gansu, China · Recruiting

  • Maternal and Child Health Hospital of Guiyang City

    Guiyangtou, Guizhou, China · Recruiting

  • Maternal and Child Health Hospital of Hainan province

    Haikou, Hainan, China · Recruiting

  • Hebei Provincial People's Hospital

    Shijiazhuang, Hebei, China · Recruiting

  • First Affiliated Hospital of Henan University of Science and Technology

    Zhengzhou, Henan, China · Recruiting

  • Maternal and Child Health Hospital of Hubei province

    Wuhan, Hubei, China · Recruiting

  • First People's Hospital of Changzhou City

    Changzhou, Jiangsu, China · Recruiting

  • First People's Hospital of Lianyungang City

    Lianyungang, Jiangsu, China · Recruiting

  • Jiangsu Provincial Hospital of Chinese Traditional medicine

    Nanjingkou, Jiangsu, China · Recruiting

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, China · Recruiting

  • Suzhou City Hospital

    Suzhou, Jiangsu, China · Recruiting

  • Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Recruiting

  • Maternal and Child Health Hospital of Tai'an city

    Tai’an, Shandong, China · Recruiting

  • Children's Hospital of Chengdu city

    Chengdu, Sichuan, China · Recruiting

  • People's Hospital of Cixi City

    Cixi, Zhejiang, China · Recruiting

  • First People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • First People's Hospital of Jiaxing City

    Jiaxing, Zhejiang, China · Recruiting

  • Jinhua Central Hospital

    Jinhua, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.